Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 40,000 shares at $86.37 ($3.4M) on 2025-10-01, disclosed to the SEC on 2025-10-03.
Scheduled sale ($3.4M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.43 | 19,030 | $1.6M | 47.5% |
| 2 | $85.43 | 19,030 | $1.6M | 47.5% |
| 3 | $86.37 | 970 | $84K | 2.5% |
| 4 | $86.37 | 970 | $84K | 2.5% |
| Total | $85.48 avg | 40,000 | $3.4M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |